Chapter 25. Non-steroidal Anti-inflammatory Agents

[1]  I. Harrison,et al.  Nonsteroidal antiinflammatory agents. I. 6-substituted 2-naphthylacetic acids. , 1970, Journal of medicinal chemistry.

[2]  B. Steinetz,et al.  Influence of Thyroidectomy and Thyroid Hormones on Adjuvant Arthritis in Rats , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  F. Paronetto.  Adjuvant Arthritis Induced by Corynebacterium rubrum 1 , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[4]  G. Kersley.  Long-term use of allopurinol in the treatment of gout. , 1970, Annals of the rheumatic diseases.

[5]  N. Anand,et al.  Antifertility agents. IV. 2,3-diphenylbenzo- and 5,6-polymethylenebenzofurans, 1,2-diphenylnaphthofurans, and some related compounds. , 1970, Journal of medicinal chemistry.

[6]  D. Kvam,et al.  Antiinflammatory agents. I. 3-Benzoylfluoroalkanesulfonamides. , 1970, Journal of medicinal chemistry.

[7]  R. Filderman,et al.  Anti‐inflammatory activity of the steroid alkaloid glycoside, tomatine , 1969 .

[8]  D. Delong,et al.  Heterocyclic substituted ureas. I. Immunosuppression and virus inhibition by benzimidazoleureas. , 1969, Journal of medicinal chemistry.

[9]  T. Chalmers,et al.  Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflammatory agent. I. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis. , 1969, Annals of the rheumatic diseases.

[10]  B. Steinetz,et al.  Abnormal Sulfhydryl-Disulfide Interchange in Serum of Rats with Adjuvant Arthritis , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  J. Kellgren,et al.  Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflamatory agent. II. Clinical trial in patients with rheumatoid arthritis. , 1969, Annals of the rheumatic diseases.

[12]  I. Tsukada,et al.  An anti-inflammatory proteinase, kinonase BI obtained from Streptomyces kinoluteus. , 1969, Chemical & pharmaceutical bulletin.

[13]  F. Short,et al.  Synthesis and interconversion of 6-aroyl-4-oxohexanoie acids and 5-aryl-2-furanpropionic acids. Antiinflammatory agents , 1969 .

[14]  F. Short,et al.  Synthesis and structure of 5-oxo-1-phenylpyrazoline-3- and 4-alkanoic acids. Antiinflammatory agents , 1969 .

[15]  L. Long,et al.  Synthesis of 5-aryl-2-oxazolepropionic acids and analogs. Antiinflammatory agents , 1969 .

[16]  D. Lewis,et al.  Stabilising action of anti-inflammatory steroids on lysosomes. , 1969, Biochemical pharmacology.

[17]  J. Mendelson,et al.  The inhibition of adjuvant disease in rats by the interferon-inducine agent pyran copolymer. , 1969, Arthritis and rheumatism.

[18]  D. Lednicer,et al.  Synthesis and antiinflammatory activity of 5-substituted 2,3-bis(p-methoxyphenyl)indoles. , 1969, Journal of medicinal chemistry.

[19]  J. A. Crim,et al.  Immunosuppressive effects of adamantoyl cytarabine. I. Inhibition of hemagglutinin formation and graft versus host reactions in mice. , 1969, Biochemical pharmacology.

[20]  T. Chalmers.  Clinical experience with Ibuprofen in the treatment of rheumatoid arthritis. , 1969, Annals of the rheumatic diseases.

[21]  M. K. Jasani,et al.  Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases. Origin and relation to disease category. , 1969, Annals of the rheumatic diseases.

[22]  A. Oronsky,et al.  Effect of Sulphydryl Binding Compounds on the Inflammatory Process , 1969, Nature.

[23]  P. Y. Paterson,et al.  Cyclophosphamide: Effect on Experimental Allergic Encephalomyelitis in Lewis Rats , 1969, Science.

[24]  J. Bennett,et al.  Possible Usefulness of Azathioprine (Imuran) In Severe Rheumatoid Arthritis , 1969 .

[25]  R. Perper,et al.  Separation of Anti-inflammatory and Immunosuppressive Activities in Heterologous Antilymphocyte Serum , 1969, Nature.

[26]  R. Lisciani,et al.  Erythrocyte membrane stabilization and protein binding of some anti-inflammatory drugs and of deoxycholic acid. , 1969, Biochemical pharmacology.

[27]  L. Sancilio.  Evans blue-carrageenan pleural effusion as a model for the assay of nonsteroidal antirheumatic drugs. , 1969, The Journal of pharmacology and experimental therapeutics.

[28]  P. Dykes,et al.  Transport of gold in the body. , 1969, Annals of the rheumatic diseases.

[29]  A. Anderson.  Effects of lysosomal collagenolytic enzymes, anti-inflammatory drugs and other substances on some properties of insoluble collagen. , 1969, The Biochemical journal.

[30]  J. Fraser,et al.  Influence of serum on secretion of hyaluronic acid by synovial cells. Its possible relevance in arthritis. , 1969, Annals of the rheumatic diseases.

[31]  J. Bach,et al.  In vitro Evaluation of Immunosuppressive Drugs , 1969, Nature.

[32]  Singh Rh,et al.  Annanase induced degenerative arthritis and the effect of an indigenous drug. , 1969 .

[33]  J. Brown,et al.  Interaction of Lysosomes and Anti-inflammatory Drugs , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[34]  M. Rocha e Silva,et al.  Anti-inflammatory action of sulfated polysaccharides. , 1969, Biochemical pharmacology.

[35]  Y. Mizushima,et al.  Stabilization of erythrocyte membrane by non‐steroid anti‐inflammatory drugs , 1969, The Journal of pharmacy and pharmacology.

[36]  J. Cummings,et al.  CL 65,562 (4-(a,a,a-trifluoro-m-toluidino)-nicotinic acid), a novel "high ceiling" diuretic. , 1969, The Journal of pharmacology and experimental therapeutics.

[37]  T. Hudyma,et al.  Preparation and antiinflammatory properties of some 1-substituted 3-(5-tetrazolylmethyl)indoles and homologs. , 1969, Journal of medicinal chemistry.

[38]  S. Kadin,et al.  Dioxoisoquinoline-4-carboxanilides—A New Class of Non-steroidal Anti-inflammatory Agents , 1969, Nature.

[39]  M. B. Gupta,et al.  Anti-inflammatory activity of natural products. I. Triterpenoids. , 1969, European journal of pharmacology.

[40]  B. Bowman,et al.  In Vitro Effects of Non-steroidal Anti-inflammatory Drugs (NAIFD) , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[41]  S. Krane,et al.  Synovial collagenase: its presence in culture from joint disease of diverse etiology. , 1969, Arthritis and rheumatism.

[42]  H. Yamaki,et al.  An anti-inflammatory proteinase, kinonase AI and A3 obtained from a Streptomyces. , 1969, Chemical & pharmaceutical bulletin.

[43]  D. Griswold,et al.  Immunosuppressant effect of salicylate and quinine on antibody forming cells. , 1969, European journal of pharmacology.

[44]  B. Newbould.  The pharmacology of fenclozic acid (2‐(4‐chlorophenyl)‐thiazol‐4‐ylacetic acid; I.C.I. 54, 450; ‘Myalex’); a new compound with anti‐inflammatory, analgesic and antipyretic activity , 1969, British journal of pharmacology.

[45]  A. Benakis,et al.  Distribution, excretion metabolism and localization of a new anti-inflammatory drug: niflumic acid, labelled with 14C. , 1969, Biochemical pharmacology.

[46]  M. K. Jasani,et al.  Effect of Glyvenol (CIBA) on pain and on capillary resistance in rheumatoid arthritis. , 1969, Annals of the rheumatic diseases.

[47]  A. Inglot.  Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs. , 1969, The Journal of general virology.

[48]  Calvin G. Barnes,et al.  Azathioprine in Rheumatoid Arthritis , 1969, British medical journal.

[49]  Maxson Tr,et al.  Controlled study of a new antiarthritic substance. , 1969 .

[50]  H. Izumi,et al.  [Uracil derivatives and related compounds. IX. Synthesis of bucolome's related compounds. (4)]. , 1969, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[51]  H. Fujimura,et al.  [Uracil derivatives and related compounds. 8. Synthesis and anti-inflammatory activity of bucolome's related compounds. (3)]. , 1969, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[52]  R. Marcolongo,et al.  Liver xanthine oxidase in gouty patients. , 1969, Arthritis and rheumatism.

[53]  C. Pearson,et al.  Inhibition of adjuvant arthritis by protein antigens. I. Inhibitory capacities and dose relationships of different proteins. , 1969, Immunology.

[54]  S. C. Lyster,et al.  Induction of Inflammation, Fever, and Acceleration of Adjuvant-Disease by Surfactants , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[55]  K. Doebel.  The chemistry of non-steroidal anti-inflammatory agents , 1969, Pure and applied chemistry. Chimie pure et appliquee.

[56]  Z. Kuratowska,et al.  Haematological changes in adjuvant disease in the rat. I. Peripheral blood and bone marrow after repeated injections of Freund's adjuvant. , 1969, Annals of the rheumatic diseases.

[57]  E. Fujihira,et al.  Antiinflammatory Activities of Related Compounds to Anthranilic Acid. I. : On N-Phenylanthranilic Acid Derivatives , 1969 .

[58]  A. Benakis,et al.  Synthèse et purification de l'acide (trifluorométhyl-3-phénylamino)-2-nicotinique (acide niflumique) à Carboxyle [14C], d'activité spécifique élevée† , 1969 .

[59]  G. Wulff,et al.  Über triterpene—XXVI: Über die struktur der rosskastaniensaponnie (Aescin) und die aglykone verwandter glykoside☆ , 1969 .

[60]  J. Patkowski,et al.  Studies on the immunopharmacologic properties of tris-(Chloroethyl)-amine (TS160). , 1969, Archivum immunologiae et therapiae experimentalis.

[61]  J. Krapcho,et al.  Immunosuppressive acitivity of 2'-(3-dimethylaminopropylthio)cinnamanilide (cinanserin) and related compounds. IV. , 1969, Journal of medicinal chemistry.

[62]  L. E. Siltzbach,et al.  Arthritis in sarcoidosis. , 1969, Clinical orthopaedics and related research.

[63]  F. Delbarre,et al.  [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)]. , 1968, La Presse medicale.

[64]  Glenn Em.  Inhibition of Adjuvant-Induced Polyarthritis with Cytarabine , 1968 .

[65]  A. S. Posner,et al.  Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases. , 1968, Arthritis and rheumatism.

[66]  I. Jaffe,et al.  Rheumatoid vasculitis. Report of a second case treated with penicillamine. , 1968, Arthritis and rheumatism.

[67]  J. Gougeon,et al.  [Clinical assay of niflumic acid in rheumatology]. , 1968, Therapie.

[68]  D. Willoughby,et al.  An analysis of the effects of some types of anti-lymphocyte sera on contact hypersensitivity and certain models of inflammation. , 1968, Immunology.

[69]  C. Lack.  Experimental models of rheumatoid arthritis. , 1968, The Medical clinics of North America.

[70]  L. Ward.  NONSTEROID ANTI‐INFLAMMATORY AGENTS IN THE THERAPY OF RHEUMATIC DISEASES , 1968, Journal of the American Geriatrics Society.

[71]  S. Paltemaa.  The inhibition of lysosomal enzymes by gold salts in human synovial fluid cells. , 1968, Acta rheumatologica Scandinavica.

[72]  S. P. Leinbach.  COUNCIL ON DRUGS , 1959 .

[73]  W. Copeman.  Textbook of the Rheumatic Diseases , 1949 .